QuantumScape (QS) Stock Explodes After Major Factory Breakthrough
June 25 QuantumScape (NYSE:QS) stock surged about 45% in Wednesday morning trade after the company reported a key breakthrough in battery production.
Warning! GuruFocus has detected 2 Warning Sign with QS.
The electric vehicle battery developer said it has integrated its new Cobra separator into baseline cell production. The updated process improves heat treatment speeds nearly 25 times over its previous Raptor method and reduces equipment footprint, potentially easing scale-up for future gigafactories.
The company described the upgrade as a "powerful path forward" toward bringing its solid-state battery technology to market. CEO Dr. Siva Sivaram said the Cobra system enhances throughput while optimizing space efficiency.
QuantumScape's latest development may support commercial goals, but analysts will be watching for consistent output at scale. While the tech promises higher efficiency, timing and execution could weigh on future investor sentiment.
The milestone offers a potential turning point, though the road to commercialization remains long. Market response shows renewed interest, but staying power will depend on delivery.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
‘Here's What to Expect Next,' Says UBS About UnitedHealth Stock
UnitedHealth (NYSE:UNH) investors have had little to shout about in 2025. The stock has shed 40% of its value year-to-date due to a host of negative developments. Confident Investing Starts Here: A positive early-year narrative began to unravel following underwhelming first-quarter results and a May 13 update, which revealed a CEO transition and the suspension of forward guidance – moves that hinted at deeper structural issues. Chief among the concerns were rising costs tied to Medicare Advantage members at UHC and coding challenges among new Optum enrollees from 2024. The situation deteriorated further when the Wall Street Journal reported that the Department of Justice had launched a Medicare fraud investigation into the company. Against this troubled backdrop, UNH's annual meeting on June 2 brought a potential turning point. Returning CEO Stephen Hemsley announced that the company plans to reinstate its 2025 guidance alongside its Q2 earnings report on July 29, while also cautioning that the new outlook would be 'prudent.' That comment alone sent a signal to Wall Street that the revised forecast could come in well below prior expectations. UBS analyst AJ Rice notes that investors have interpreted Hemsley's tone as a cue to brace for a more conservative guide than the current consensus EPS of $22.50 for 2025. In the days following the meeting, buy-side expectations have drifted lower, with many now anticipating a 2025 EPS closer to $20. Is that a too pessimistic take? Rice isn't sure. 'In our on-going discussions with the company, we do not get affirmation that such an estimate is correct, but we also do not get discouragement that such a number is out of line,' he explained. In light of the uncertainty, Rice has adjusted his model to reflect the $20 EPS view. His revised assumptions include a 50 basis point cut to Medicare Advantage margins (now at 1.5%) and a trim to Optum Health's margin from 5.0% to 4.5%. He also flags potential weakness ahead across the broader risk insurance portfolio. While UNH previously claimed conservative pricing in its commercial book, management has since clarified that this mainly applies to the Exchange business, which has shown weaker enrollment compared to peers. Meanwhile, higher-than-expected costs persist in the core commercial risk book, fueling worries about broader 'mis-pricing' – particularly given the volatility already observed in government-related segments. 'Finally,' Rice concludes, 'we believe the company wants to offer a new 2025 outlook that it can be assured of delivering and, therefore, we expect the number to be even more conservative than normal, when all is said and done.' Accordingly, the analyst has lowered his price target from $400 to $385, still implying a 27% upside over the next 12 months. Despite the trimmed outlook, Rice maintains a Buy rating on the stock. (To watch Rice's track record, click here) His view is largely echoed across the Street. Of the 26 analysts covering UNH stock, 18 rate it a Buy, with 7 Holds and just 1 Sell, resulting in a Moderate Buy consensus. The average price target stands at $361.91, suggesting potential 12-month returns of ~20%. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Upturn
2 hours ago
- Business Upturn
Mars' Pending Acquisition of Kellanova Clears FTC Antitrust Review
CHICAGO, McLean, Va., United States: Mars, Incorporated, a family-owned, global leader in pet care, snacking and food, and Kellanova (NYSE: K), a leader in global snacking, international cereal and noodles and North America frozen foods, today announced that the U.S. Federal Trade Commission (FTC) has concluded its antitrust review of Mars' pending acquisition of Kellanova. Poul Weihrauch,CEO & Office of the President, Mars, Incorporated, said: 'We are very pleased that the FTC has completed its review of the transaction without the imposition of any condition or requiring any remedy. The transaction has now received all but one of the 28 required regulatory clearances, with only the review by the European Commission outstanding. This brings us one step closer to uniting two iconic businesses with complementary footprints and portfolios, allowing us to deliver more choice and innovation to consumers.' Steve Cahillane, Chairman, President & CEO, Kellanova, said: 'This represents a significant milestone on our path to combine Mars Snacking and Kellanova. We continue to believe this is an exciting opportunity to create a broader, global snacking business that is better positioned to meet evolving consumer needs and preferences.' Based on the current status of the ongoing antitrust review by the European Commission, Mars and Kellanova expect the transaction to close towards the end of 2025, subject to customary closing conditions. The exact timing cannot be predicted with any certainty at this point. About Mars, Incorporated Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As a global, family-owned business, Mars is transforming, innovating, and evolving to make a positive impact on the world. Across our diverse and expanding portfolio of quality snacking, food, and pet care products and services, we employ 150,000+ dedicated Associates. With more than $50 billion in annual sales, we produce some of the world's best-loved brands including Ben's Original™, CESAR®, Cocoavia®, DOVE®, EXTRA®, KIND®, M&M's®, SNICKERS®, PEDIGREE®, ROYAL CANIN®, and WHISKAS®. We are creating A Better World for Pets through our global network of pet hospitals and diagnostic services – including AniCura, BANFIELD™, BLUEPEARL™, Linnaeus and VCA™ – using cutting edge technology to develop breakthrough programs in genetic health screening and DNA testing. For more information about Mars, please visit Join us on Facebook, Instagram, LinkedIn and YouTube. About Kellanova Kellanova (NYSE: K) is a leader in global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching back more than 100 years. Powered by differentiated brands including Pringles®, Cheez-It®, Pop-Tarts®, Kellogg's Rice Krispies Treats®, RXBAR®, Eggo®, MorningStar Farms®, Special K®, Coco Pops®, and more, Kellanova's vision is to become the world's best-performing snacks-led company, unleashing the full potential of our differentiated brands and our passionate people. Our Net Sales for 2023 were $13 Billion. At Kellanova, our purpose is to create better days and ensure everyone has a seat at the table through our trusted food brands. We are committed to promoting sustainable and equitable food access by tackling the crossroads of hunger, sustainability, wellbeing, and equity, diversity & inclusion. Our goal is to create Better Days for 4 billion people by the end of 2030 (from a 2015 baseline). For more detailed information about our commitments, our approach to achieving these goals, and methodology, please visit our website at Forward-Looking Statements This press release, and any related oral statements, includes statements that constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended, including statements regarding the pending acquisition (the 'Merger') of Kellanova (the 'Company') by Mars, Incorporated ('Mars'), regulatory approvals, the expected timetable for completing the Merger, the expected benefits and other effects of the Merger, the integration of the companies, the combined business going forward and any other statements regarding the Company's future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical facts. This information may involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to: the timing to consummate the Merger and the risk that the Merger may not be completed at all or the occurrence of any event, change, or other circumstances that could give rise to the termination of the merger agreement, including circumstances requiring a party to pay the other party a termination fee pursuant to the merger agreement; the risk that the conditions to closing of the Merger may not be satisfied or waived; the risk that a governmental or regulatory approval that may be required for the Merger is not obtained or is obtained subject to conditions that are not anticipated; potential litigation relating to, or other unexpected costs resulting from, the Merger; legislative, regulatory, and economic developments; risks that the Merger disrupts the Company's current plans and operations; the risk that certain restrictions during the pendency of the Merger may impact the Company's ability to pursue certain business opportunities or strategic transactions; the diversion of management's time on transaction-related issues; continued availability of capital and financing and rating agency actions; the risk that any announcements relating to the Merger could have adverse effects on the market price of the Company's common stock, credit ratings or operating results; and the risk that the proposed transaction and its announcement could have an adverse effect on the ability to retain and hire key personnel, to retain customers and to maintain relationships with business partners, suppliers and customers. All statements, other than statements of historical fact, should be considered forward-looking statements made in good faith by the Company, as applicable, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. When used in this communication, or any other documents, words such as 'anticipate,' 'believe,' 'estimate,' 'expect,' 'forecast,' 'goal,' 'intend,' 'objective,' 'plan,' 'project,' 'seek,' 'strategy,' 'target,' 'will' and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the beliefs and assumptions of management at the time that these statements were prepared and are inherently uncertain. Such forward-looking statements are subject to risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in the forward-looking statements. These risks and uncertainties, as well as other risks and uncertainties that could cause the actual results to differ materially from those expressed in the forward-looking statements, are described in greater detail in the Company's reports filed with the United States Securities and Exchange Commission (the 'SEC'), including the Company's Annual Report on Form 10-K for the year ended December 28, 2024, subsequent Quarterly Reports on Form 10-Q, Current Reports on Forms 8-K and other SEC filings made by the Company. The Company cautions that these risks and factors are not exclusive. Management cautions against putting undue reliance on forward-looking statements or projecting any future results based on such statements or present or prior earnings levels. Forward-looking statements speak only as of the date of this Report, and, except as required by applicable law, the Company does not undertake any obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
3 hours ago
- Yahoo
Perfect Corp. (PERF) Partners with NVIDIA to Enhance AI Beauty and Fashion Solutions
Perfect Corp. (NYSE:PERF) is one of the 7 most popular AI penny stocks under $5 to avoid. On June 11, Perfect revealed a 'groundbreaking' partnership with Nvidia (NASDAQ:NVDA) to enhance its suite of next-generation beauty and fashion technology solutions. Specifically, Perfect will integrate Nvidia's AI and accelerate computing platforms into its products. According to Perfect, this integration will help to deliver hyper-personalized experiences with unparalleled realism, accuracy, and speed in the beauty and fashion industries. A fashion model in a stunning and stylish outfit leveraging augmented reality beauty and fashion tech. Perfect's AI Skincare solution uses deep-learning AI models trained on over 70,000 medical-grade images to detect up to 15 skin conditions in real time. It is optimized with NVIDIA TensorRT for lightning-fast runtime performance. On the other hand, YouCam Online Editor offers Generative AI features, including AI Hairstyle Generation and AI Video Face Swap. This, too, leverages NVIDIA TensorRT, which optimizes generative diffusion models for real-time creation of personalized hairstyles, face swaps, and clothing try-ons. Thus, integrating Nvidia's technology into the solutions addresses several critical challenges. The main ones are achieving true-to-life color representation and adapting to diverse skin tones and types. Perfect Corp. (NYSE:PERF) is an AI and augmented reality software company headquartered in New Taipei City, Taiwan. The firm creates digital solutions for the beauty, fashion, and skincare industries. Its key products include the YouCam app suite and the WANNA virtual try-on platform. While we acknowledge the potential of PERF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs China Stocks: 10 Stocks to Buy and 10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing. Disclosure: None. Sign in to access your portfolio
